BA arrives at its July 28 Q2 earnings report having shed 8% over the past month and nearly 6% in the past week alone, closing Tuesday at $204.80 — a setup that places the Street's mean target of $270 roughly 32% above the current price, a gap that tells you exactly how much recovery the bulls are still waiting for.
The most telling dynamic this week isn't short interest, which barely registers as a concern. At just 1.85% of the free float, shorts have been quietly reducing exposure — down 15% over the past month — and borrow conditions remain trivially loose, with availability running above 5,500% and cost-to-borrow at 0.42%. That is not a market betting heavily against Boeing. What is more interesting is the direction of the stock itself, which has accelerated lower even as short sellers trim positions. The selling pressure is coming from somewhere else.
Options positioning reflects mild caution rather than outright fear. The put/call ratio at 0.84 is just barely above its 20-day average of 0.82 — less than one standard deviation from the norm — and well short of the 52-week defensive extreme of 1.03. Heading into a print that moved the stock almost 7% the day after Q1 results in April, that relative calm in options is notable. Either the market is less worried than the price action suggests, or hedges are being placed through other instruments.
The Street's view is constructive but increasingly stale. The most recent analyst change in the data was Citigroup lifting its target to $260 back in May, with Morgan Stanley at $250 and Wells Fargo's April initiation at Overweight with a $250 target. The consensus sits at hold, with the mean target at $270 — implying meaningful upside but with six holds in the mix reflecting genuine uncertainty about the pace of Boeing's operational recovery. EPS momentum is a genuine bright spot: the factor scores rank it in the 95th percentile on 30-day EPS momentum and the 97th percentile on 90-day momentum. The catch is a near-bottom-decile ranking on EPS surprise and a rock-bottom score on forward EPS year-on-year growth — analysts are revising up, but from a deeply negative base. The P/E multiple, while still elevated at roughly 100x trailing, has compressed by around 27 points over the past month as the stock drifted lower.
Institutional holders show incremental accumulation rather than conviction buying. BlackRock added roughly 1.5 million shares as of June 30, bringing its stake to 7.5% of the company. FMR added 3.7 million shares over the same period. These are passive and quasi-passive flows — useful as a floor check, but not the kind of active positioning that signals a strong fundamental thesis being pressed. Insider activity is similarly muted: the only meaningful recent buy was a director purchasing just under $300,000 in May at $218.50 — above today's price, which is a small and accidental confirmation that insiders were not anticipating the recent leg down.
Aerospace peers had a mixed week alongside Boeing. GE fell 3.7% on the week, broadly tracking BA's direction, while HWM eked out a small gain and HXL posted a strong 6.7% move higher. The divergence between Boeing and some of its supply-chain peers suggests the weakness is company-specific rather than sector-wide — which puts the burden squarely on what the July 28 report delivers.
The Q1 print moved the stock nearly 7% on the day and held about a 2% gain through the following week. The July 28 release arrives with the stock at a lower base, the Street priced for recovery, and the question less about whether Boeing's turnaround is happening and more about whether the pace is fast enough to justify a multiple that still prices in substantial improvement.
See the live data behind this article on ORTEX.
Open BA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
